SMIRNE, Carlo
 Distribuzione geografica
Continente #
NA - Nord America 4.123
EU - Europa 3.476
AS - Asia 2.374
SA - Sud America 331
Continente sconosciuto - Info sul continente non disponibili 128
AF - Africa 71
OC - Oceania 7
Totale 10.510
Nazione #
US - Stati Uniti d'America 3.966
SG - Singapore 944
RU - Federazione Russa 855
IE - Irlanda 604
IT - Italia 491
CN - Cina 488
DE - Germania 382
SE - Svezia 315
VN - Vietnam 308
HK - Hong Kong 271
BR - Brasile 250
FR - Francia 231
UA - Ucraina 199
FI - Finlandia 126
GB - Regno Unito 117
IN - India 103
CA - Canada 80
KR - Corea 56
BD - Bangladesh 44
ID - Indonesia 42
AR - Argentina 33
PL - Polonia 30
BJ - Benin 25
MX - Messico 24
AT - Austria 22
CZ - Repubblica Ceca 22
ZA - Sudafrica 21
JP - Giappone 17
NL - Olanda 17
BE - Belgio 16
TR - Turchia 16
EC - Ecuador 14
IQ - Iraq 14
CL - Cile 11
ES - Italia 11
CO - Colombia 9
IR - Iran 9
PH - Filippine 8
AU - Australia 7
GT - Guatemala 7
VE - Venezuela 7
CR - Costa Rica 6
HN - Honduras 6
JM - Giamaica 6
JO - Giordania 6
KE - Kenya 6
PK - Pakistan 6
PR - Porto Rico 6
TH - Thailandia 6
TT - Trinidad e Tobago 6
UZ - Uzbekistan 6
AL - Albania 5
CH - Svizzera 5
EG - Egitto 5
SV - El Salvador 5
CW - ???statistics.table.value.countryCode.CW??? 4
DZ - Algeria 4
EE - Estonia 4
LT - Lituania 4
NP - Nepal 4
PY - Paraguay 4
AE - Emirati Arabi Uniti 3
DO - Repubblica Dominicana 3
MA - Marocco 3
OM - Oman 3
PS - Palestinian Territory 3
SA - Arabia Saudita 3
AZ - Azerbaigian 2
BS - Bahamas 2
DK - Danimarca 2
GP - Guadalupe 2
HR - Croazia 2
IL - Israele 2
LV - Lettonia 2
MD - Moldavia 2
MK - Macedonia 2
MY - Malesia 2
NI - Nicaragua 2
PE - Perù 2
PT - Portogallo 2
RO - Romania 2
RS - Serbia 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
BZ - Belize 1
CI - Costa d'Avorio 1
CY - Cipro 1
ET - Etiopia 1
GH - Ghana 1
GM - Gambi 1
IM - Isola di Man 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
LY - Libia 1
Totale 10.382
Città #
Dublin 604
San Jose 510
Jacksonville 363
Hong Kong 265
Ashburn 253
Council Bluffs 244
Singapore 201
Dearborn 166
Chandler 152
Beijing 140
Columbus 120
Los Angeles 109
Ho Chi Minh City 92
Wilmington 91
Moscow 87
Ann Arbor 81
Piemonte 76
Lauterbourg 72
Lawrence 71
Princeton 71
Hanoi 70
Milan 67
Santa Clara 62
San Mateo 58
Seoul 53
Buffalo 51
New York 51
Novara 46
Munich 42
Andover 41
Phoenix 39
Denver 34
Turin 33
São Paulo 31
Brooklyn 30
Jakarta 29
Chicago 28
Atlanta 27
Houston 27
Nuremberg 27
Dallas 26
Frankfurt am Main 26
Warsaw 26
Cotonou 25
Helsinki 21
Brno 20
Orem 20
Toronto 20
Guangzhou 18
Nanjing 18
Hillsboro 17
Brussels 16
Dong Ket 16
Rome 16
Boardman 15
Johannesburg 15
London 15
Montreal 15
Chennai 14
Haiphong 14
Tianjin 14
Hefei 13
Tokyo 13
Woodbridge 13
Mexico City 12
Norwalk 12
Poplar 12
Redondo Beach 12
Schaumburg 12
Seattle 12
Stockholm 12
Boston 11
Da Nang 11
Falkenstein 11
Philadelphia 11
Shanghai 11
Düsseldorf 10
Mumbai 10
North Bergen 10
Manchester 9
Brasília 8
Bremen 8
Newark 8
San Francisco 8
Turku 8
Augusta 7
Charlotte 7
City of London 7
Grafing 7
Strasbourg 7
Vercelli 7
Alessandria 6
Amman 6
Berlin 6
Bologna 6
Fairfield 6
Guatemala City 6
Hangzhou 6
Jinan 6
Kunming 6
Totale 5.354
Nome #
Expression of the interferon-inducible proteins MxA and IFI16 in liver allografts 292
Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients 275
Genetic polymorphisms of inflammatory cytokines and liver fibrosis progression due to recurrent hepatitis C 237
Simple Parameters from Complete Blood Count Predict In-Hospital Mortality in COVID-19 214
Contribution of Atrial Fibrillation to In-Hospital Mortality in Patients With COVID-19 205
Extracellular Vesicles as a Potential Biomarker of Pulmonary Arterial Hypertension in Systemic Sclerosis 197
Response rates to direct antiviral agents among hepatitis C virus infected patients who develop hepatocellular carcinoma following direct antiviral agents treatment 177
Antiviral treatment of hepatitis C improves glucose metabolism along the entire spectrum from normal glucose tolerance to diabetes 163
Validation of the Hepatoma Arterial Embolization Prognostic Score in European and Asian Populations and Proposed Modification. 152
Detrimental Impact of Interferon-Based Regimens for Chronic Hepatitis C on Vitamin D/Parathyroid Hormone Homeostasis 152
Oxidative Stress in Non-Alcoholic Fatty Liver Disease 151
Evaluation of the red cell distribution width as a biomarker of early mortality in hepatocellular carcinoma 147
Red cell distribution width and platelet count as biomarkers of pulmonary arterial hypertension in patients with connective tissue disorders 146
Plasma microvesicles in patients admitted to the emergency department for mild traumatic brain injury: First clues to understand their role 142
Improvement of insulin sensitivity in diabetic and non diabetic patients with chronic hepatitis C treated with direct antiviral agents 141
Combined sequential use of HAP and ART scores to predict survival outcome and treatment failure following chemoembolization in hepatocellular carcinoma: A multi-center comparative study 140
Asymptomatic HBV and HCV carriers, bad breath and gengivitis 139
Aberrant activation of c-kit protects colon carcinoma cells against apoptosis and enhances their invasive potential 138
Gas6/TAM Signaling Components as Novel Biomarkers of Liver Fibrosis 138
Unusual presentation of fatal disseminated varicella zoster virus infection in a patient with lupus nephritis: A case report 134
Diagnostic value of FibroTest with normal serum aminotransferases 132
Antagonistic interactions between gemcitabine and 5-fluorouracil in the human pancreatic carcinoma cell line Capan-2 130
Differential expression of transforming growth factors-beta1, -beta2 and -beta3 in human colon carcinoma 127
Risk of hepatocellular carcinoma and death among cirrhotics who carry genetic variants of epidermal growth factor, Adiponutrin and 17β-Hydroxysteroid Dehydrogenase-13: a long-term cohort study 126
Cooperative induction of a tolerogenic dendritic cell phenotype by cytokines secreted by pancreatic carcinoma cells 126
APOLIPOPROTEIN E GENOTYPES MODULATE FIBROSIS PROGRESSION IN PATIENTS WITH CHRONIC HEPATITIS C AND PERSISTENTLY NORMAL TRANSAMINASES 125
Periostin Circulating Levels and Genetic Variants in Patients with Non-Alcoholic Fatty Liver Disease 125
Role of the co-stimulatory molecule inducible T-cell co-stimulator ligand (ICOSL) in the progression of experimental metabolic dysfunction-associated steatohepatitis 123
The surgical treatment of lung metastases. The prognostic factors and the indications for the surgical approach 123
Assessment of liver fibrosis progression in patients with chronic hepatitis C and normal alanine aminotransferase values: the role of the AST to platelet ratio index 123
Cytokine expression profile in human pancreatic carcinoma cells and in surgical specimens: implications for survival 123
ACE genotype, body weight changes and target organ damage in renal transplant recipients 123
The ALBI grade provides objective hepatic reserve estimation across each BCLC stage of hepatocellular carcinoma 122
Role of Gas6 and TAM Receptors in the Identification of Cardiopulmonary Involvement in Systemic Sclerosis and Scleroderma Spectrum Disorders 121
IL28B Polymorphism, Blood Interferon-alpha Concentration, and Disease Stage of HCV Mono-infected and HCV-HIV Co-infected Patients. 117
Plasma Pattern of Extracellular Vesicles Isolated from Hepatitis C Virus Patients and Their Effects on Human Vascular Endothelial Cells 116
Chronic Hepatitis C Infection Treated with Direct-Acting Antiviral Agents and Occurrence/Recurrence of Hepatocellular Carcinoma: Does It Still Matter? 115
Chlamydia trachomatis prevalence in North-West Italy 114
Interferon alpha concentrations in blood and peritoneal fluid during treatment for hepatitis C 112
Fibrosis Progression in HCV Carriers with Mild Hepatitis Who Possess the High-Repetition Variant of the DRD4 Gene, a Genetic Marker for Binge-Drinking and Risk-Seeking Behavior: A Longitudinal Study. 111
Sofosbuvir-based therapies in genotype 2 hepatitis C virus cirrhosis: A real-life experience with focus on ribavirin dose 110
Plasma Extracellular Vesicles from Preeclamptic Patients Trigger a Detrimental Crosstalk Between Glomerular Endothelial Cells and Podocytes Involving Endothelin-1 109
Acquired post partum hemophilia 109
Low fibrosis progression of recurrent hepatitis C in apolipoprotein E epsilon4 carriers: relationship with the blood lipid profile 109
The spectrum of movement disorders in chronic liver disease: A cross-sectional study 107
Genetic polymorphisms of interleukin-6 modulate fibrosis progression in mild chronic hepatitis C. 106
Durability of the response to peginterferon-α2b and ribavirin in patients with chronic hepatitis C 105
Clinical Characteristics and Outcomes in Patients with Chronic HBV Infection and Hospitalized for COVID-19 Pneumonia: A Retrospective Cohort Study 104
The spectrum of movement disorders in chronic liver disease: a cross-sectional study 104
Influence of angiotensin-converting enzyme I/D gene polymorphism on clinical and histological correlates of chronic hepatitis C 103
T-cell mediated responses against alpha-foetoprotein in hepatocellular carcinoma: Relationship with hepatitis C virus infection, tumour phenotype and patients’ survival 103
Use, misuse and abuse of diuretics 99
Human pancreatic carcinoma cells secrete bioactive interleukin-18 after treatment with 5-fluorouracil: implications for anti-tumor immune response 99
Vascular endothelial growth factor. From basic research to clinical application 99
Efficacy and Safety of Sofosbuvir and Ribavirin in an Italian Cohort of HCV Genotype 2 Elderly Cirrhotic Patients 98
Hepatitis C in the elderly: a multicentre cross-sectional study by the Italian Association for the Study of the Liver. 98
Clinical Features and Outcomes of Patients with Full Spectrum of COVID-19 Severity and Concomitant Herpesvirus Reactivation 96
Impact of Age and Sex on Viral Load in Hepatitis C Virus Infection 93
Liver biopsy and noninvasive alternatives in relationship to the duration of antiviral treatment for hepatitis C 92
Exposure to Plasma From Non-alcoholic Fatty Liver Disease Patients Affects Hepatocyte Viability, Generates Mitochondrial Dysfunction, and Modulates Pathways Involved in Fat Accumulation and Inflammation 92
The Impact of the G6PD Gene Mutations in Patients with Chronic Hepatitis C Infection Treated with Direct-Acting Antivirals: A Multicenter Observational Study 91
A novel likely pathogenetic variant p.(Cys235Arg) of the MEN1 gene in multiple endocrine neoplasia type 1 with multifocal glucagonomas. 91
High serum levels of Transforming Growth Factor-beta1, Interleukin-10 and Vascular Endothelial Growth Factor in pancreatic adenocarcinoma patients 91
Production and pro-apoptotic activity of soluble CD95 ligand in pancreatic carcinoma 91
Excess body weight, liver steatosis, and early fibrosis progression due to hepatitis C recurrence after liver transplantation 91
Hepatic arterial infusion chemotherapy for Production and pro-apoptotic activity of soluble CD95 ligand in pancreatic carcinoma 91
Imatinib mesylate for the treatment of solid tumours: Recent trials and future directions 90
Unsuspected strongyloidiasis in hospitalized elderly patients with and without eosinophilia 89
Unveiling the Mystery of Adult-Onset Still’s Disease: A Compelling Case Report 88
Pegylated interferon α plus ribavirin for the treatment of chronic hepatitis C: a multicentre independent study supported by the Italian Drug Agency. 88
Sex-related influence of angiotensin-converting enzyme polymorphisms on fibrosis progression due to recurrent hepatitis C after liver transplantation 87
The spectrum of movement disorders in chronic liver disease: a cross-sectional study 87
Hepatitis C Virus as a Possible Helper Virus in Human Hepatitis Delta Virus Infection 85
Sexually transmitted diseases and pelvic inflammatory disease 85
The pro-apoptotic factors Fas Ligand and Trail. Molecular mechanisms, physiopathological role and therapeutic potential 83
Role of AST to platelet ratio index in the detection of liver fibrosis in patients with recurrent hepatitis C after liver transplantation 83
The Kings Score refines prognostic prediction in hepatocellular carcinoma: a novel application 81
The interleukin 28B rs12979860 C/T polymorphism and serum cholesterol as predictors of fibrosis progression in patients with chronic hepatitis C and persistently normal transaminases 80
Usefulness of six non-proprietary indirect markers of liver fibrosis in patients with chronic hepatitis C 79
KIT/stem cell factor expression in premalignant and malignant lesions of the colon mucosa in relationship to disease progression and outcomes 79
Imatinib mesilate: New perspectives in the treatment of solid tumours 77
The c-kit/Stem Cell Factor in the cancerogenetic process of colon-rectal carcinoma. Biological and clinical aspects 76
Weight gain after liver transplantation and the I/D polymorphism of the angiotensin-converting enzyme gene 76
The Role of Vitamin D in Autoimmune Diseases 75
Value of two noninvasive methods to detect progression of fibrosis among HCV carriers with normal aminotransferases 75
Nitric Oxide Signaling in Cardiovascular Physiology and Pathology: Mechanisms, Dysregulation, and Therapeutic Frontiers 71
Imatinib mesylate: new perspectives in the treatment of solid tumours 70
Mitochondrial Dysfunction: The Cellular Bridge from Emo-tional Stress to Disease Onset. A narrative review 70
Evaluation of plasma interferon alpha concentration as a marker of disease severity in human psoriasis 68
Extracellular Vesicles as Mediators of Endothelial and Tubular Injury in Cardiac Surgery-Associated Acute Kidney Injury 65
What is your next step? A case of how a misleading diagnosis can mask avoidable serious adverse effects of quetiapine 33
Thinking outside the box: a case of unexplained ascites in an adult 28
Phylogenetic and genomic characterization of whole genome sequences of a herpes simplex virus type 1 isolate identified possible virulence determinants in a human subject with fulminant hepatitis 20
Liver involvement in hospitalized patients with West Nile Virus infection 14
The Modulatory Role of Vitamin D in the Molecular Mechanisms of Sepsis and Infections with Focus on Viral Pathogenesis: A Narrative Review 13
Totale 10.510
Categoria #
all - tutte 49.245
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.245


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022443 0 0 0 58 35 15 64 19 48 28 67 109
2022/20231.273 141 55 67 33 65 130 27 73 618 6 44 14
2023/2024490 35 54 35 15 87 8 93 17 14 11 42 79
2024/20251.406 25 7 45 20 26 70 160 86 249 135 218 365
2025/20263.981 153 151 250 541 394 238 638 696 284 309 221 106
2026/20271.212 183 336 370 323 0 0 0 0 0 0 0 0
Totale 10.510